Hypertension and virilization caused by a unique desoxycorticosterone- and androgen-secreting adrenal adenoma

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 2, 1999, Pages 215-220

  Soranno, D ^a   Prasad, V ^a   David, Raphael ^a   Oberfield, S ^a   Greco, A ^a   Sivaraman, N ^b   Drucker, W ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b State University of New York Health Science Center   (United States)

Author keywords

Adrenal adenoma; Androgen; Desoxycorticosterone; Hypertension; Puberty; Virilization

Indexed keywords

ANDROGEN; CORTICOTROPIN; CORTODOXONE; DEOXYCORTICOSTERONE; DEXAMETHASONE; HYDROXYPROGESTERONE; PREGNENOLONE; STEROID 11BETA MONOOXYGENASE;

ADOLESCENT; ADRENAL CORTEX ADENOMA; ANDROGEN BLOOD LEVEL; ANDROGEN RELEASE; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; SECONDARY AMENORRHEA; VIRILIZATION;

EID: 0032913985     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.2.215     Document Type: Article

References (18)

1. Ishikawa S-E, Saito T, Kaneko K, Okada K, Fukuda S, Kuzuyda T. Hypermineralo-corticism without elevation of plasma aldosterone: deoxycorticosterone-producing adrenal adenoma and hyperplasia. Clin Endocrinol 1988; 29: 367-375.
2. Kelly WF, O'Hare MJ, Loizou S, Davies D, Laing I. Hypermineralocorticism without excessive aldosterone secretion: an adrenal carcinoma producing deoxycorticosterone. Clin Endocrinol 1982; 17: 353-361.
3. Powell-Jackson JD, Calin A, Fraser R, Grahame R, Mason P, Missen GAK, Powell-Jackson PR, Wilson A. Excess deoxycorticosterone secretion from adrenocortical carcinoma. Br Med J 1974; 2: 32-33.
4. Kondo K, Saruta T, Saito I, Yoshida R, Maruyama H, Matsuki S. Benign desoxycorticosterone-producing adrenal tumor. J Am Med Assoc 1976; 236: 1042-1044.
5. Biglieri EG, Slaton PE, Schambelan M, Kronfield SJ. Hypermineralo-corticoidism. Am J Med 1968; 45: 170-175.
6. Gabrilove JL, Sabet SR, Mitty HA, Nicolis GL. Virilizing adrenal adenoma with studies on the steroid content of the adrenal venous effluent and a review of the literature. Endocr Rev 1981; 2: 462-470.
7. Ferriman D, Gallwey JD. Clinical assessment of hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447.
8. Granoff AB, Abraham GE. Peripheral and adrenal venous levels of steroids in a patient with virilizing adrenal adenoma. Obstet Gynecol 1979; 53: 111-115.
9. Irony I, Biglieri EG, Perloff D, Runoff H. Pathophysiology of desoxycorticosterone-secreting adrenal tumors. J Clin Endocrinol Metab 1987; 65: 836-840.
10. Doerr HG, Sippell WG, Drop SLS, Bidlingmaier F, Knorr D. Evidence of 11-beta hydroxylase deficiency in childhood adrenocortical tumors. Cancer 1987; 60: 1625-1629.
11. Kater CE, Czepielewski MA, Biglieri EG. Androgen-and estrogen-producing adrenocortical tumors causing hypertension. In: Biglieri EG, Melby JC, eds. Endocrine Hypertension. New York: Raven Press, Ltd., 1981; 195-206.
12. White PC, Speiser PW. Steroid 11 β-hydroxylase deficiency and related disorders. Endocrinol Metab Clin N Am 1994; 23: 325-339.
13. Sharma DC, Forchielli E, Dorfman RI. Inhibition of enzymatic 11β-hydroxylation by androgens. J Biol Chem 1963; 238: 572-575.
14. Colby HD, Skelton FR, Brownie AC. Testosterone-induced hypertension in the rat. Endocrinology 1970; 86: 1093-1101.
15. Fragachan F, Nowaczynski W, Bertranau E, Kalina M, Genest J. Evidence of in vivo 11β-hydroxylation of steroids by dehydroepiandrosterone in the dog. Endocrinology 1969; 84: 98-103.
16. McCall AL, Stern J, Dale SL, Melby JC. Adrenal steroidogenesis in methylandrostenediol-induced hypertension. Endocrinology 1978; 103: 1-5.
17. Hornsby P. Physiological and pathological effects of steroids on the function of the adrenal cortex. J Steroid Biochem 1987; 27: 1161-1171.
18. Auzeby A, Bogdan A, Touitou Y. An alternate pathway to androstenedione synthesis by human adrenals: evidence of a balance in 11β-hydroxylase and 17,20-lyase activities leading to androstenedione. J Clin Endocrinol Metab 1995; 80: 1706-1711.